Literature DB >> 17952537

Neoplastic endocrine differentiation of pancreatic ductal adenocarcinoma in a metastatic lymph node: report of a case.

Tomotaka Akatsu1, Kaori Kameyama, Yuki Nogami, Shigeyuki Kawachi, Masaki Kitajima, Yuko Kitagawa.   

Abstract

The occurrence of non-neoplastic, scattered endocrine cells in pancreatic ductal adenocarcinoma (DAC) is thought to be a general phenomenon. Conversely, neoplastic endocrine differentiation (NED) of pancreatic DAC is extremely unusual. We report a case of NED in a metastatic lymph node from pancreatic DAC. This case is distinct because the main tumor of the pancreas was composed purely of DAC without endocrine differentiation, and the NED was found in only one of four metastatic peripancreatic lymph nodes. To our knowledge, no other such case has ever been reported. The patient was a 61-year-old woman who underwent pylorus-preserving pancreaticoduodenectomy for pancreatic head cancer. Some authors reported that pancreatic DAC with endocrine differentiation was associated with a better prognosis than DAC without endocrine differentiation. However, more cases must be studied to investigate the impact of NED of metastatic lymph nodes in pancreatic DAC.

Entities:  

Mesh:

Year:  2007        PMID: 17952537     DOI: 10.1007/s00595-007-3521-9

Source DB:  PubMed          Journal:  Surg Today        ISSN: 0941-1291            Impact factor:   2.549


  17 in total

Review 1.  Mixed exocrine-endocrine tumors of the pancreas.

Authors:  G Klöppel
Journal:  Semin Diagn Pathol       Date:  2000-05       Impact factor: 3.464

2.  Mixed ductal-endocrine carcinoma of the pancreas: a possible pathogenic mechanism for arrhythmogenic right ventricular cardiomyopathy.

Authors:  E Leteurtre; F Brami; J Kerr-Conte; P Quandalle; M Lecomte-Houcke
Journal:  Arch Pathol Lab Med       Date:  2000-02       Impact factor: 5.534

3.  Endocrine-paracrine cells in pancreatic exocrine carcinomas.

Authors:  V Eusebi; C Capella; A Bondi; F Sessa; P Vezzadini; A M Mancini
Journal:  Histopathology       Date:  1981-11       Impact factor: 5.087

4.  Neuroendocrine differentiation in pancreatic duct carcinoma special emphasis on duct-endocrine cell carcinoma of the pancreas.

Authors:  T Kamisawa; M Fukayama; I Tabata; T Isawa; K Tsuruta; A Okamoto
Journal:  Pathol Res Pract       Date:  1996-09       Impact factor: 3.250

5.  Mixed ductal-endocrine carcinomas of the pancreas and ductal adenocarcinomas with scattered endocrine cells: characterization of the endocrine cells.

Authors:  N Ohike; A Jürgensen; M Pipeleers-Marichal; G Klöppel
Journal:  Virchows Arch       Date:  2003-02-06       Impact factor: 4.064

6.  Immunohistochemical study of endocrine cells in ductal adenocarcinoma of the pancreas.

Authors:  Mika Sakaki; Toshiaki Sano; Mitsuyoshi Hirokawa; Masanori Takahashi; Hiroshi Kiyoku
Journal:  Virchows Arch       Date:  2002-05-30       Impact factor: 4.064

7.  Possible primary lymph node gastrinoma: occurrence, natural history, and predictive factors: a prospective study.

Authors:  Jeffrey A Norton; H Richard Alexander; Douglas L Fraker; David J Venzon; Fathia Gibril; Robert T Jensen
Journal:  Ann Surg       Date:  2003-05       Impact factor: 12.969

8.  The gastrinoma triangle: operative implications.

Authors:  B E Stabile; D J Morrow; E Passaro
Journal:  Am J Surg       Date:  1984-01       Impact factor: 2.565

9.  Endocrine aspects of exocrine cancer of the pancreas. Their patterns and suggested biologic significance.

Authors:  P M Pour; J Permert; M Mogaki; H Fujii; K Kazakoff
Journal:  Am J Clin Pathol       Date:  1993-09       Impact factor: 2.493

Review 10.  Apparent lymph node primary gastrinoma.

Authors:  W S Arnold; D L Fraker; H R Alexander; H C Weber; J A Norton; R T Jensen
Journal:  Surgery       Date:  1994-12       Impact factor: 3.982

View more
  1 in total

1.  World Health Organization Classification (2004)-based re-evaluation of 95 nonfunctioning "malignant" pancreatic endocrine tumors reported in Japan.

Authors:  Asuka Tsuchiya; Masanori Koizumi; Haruo Ohtani
Journal:  Surg Today       Date:  2009-05-27       Impact factor: 2.549

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.